Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05175521 · ClinicalTrials.gov registry record · NA

Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine

A NA study of Migraine, sponsored by HonorHealth Research Institute.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05175521 is a NA study of Migraine that is active but no longer recruiting, run by HonorHealth Research Institute. The registered enrollment target is 50 participants, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05175521, a NA study of Migraine, is active but no longer recruiting, sponsored by HonorHealth Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to compare the efficacy and adverse events of inhaled isopropyl alcohol vapor (IAV) versus placebo (inhaled eucalyptus scent (IES) (1:20 dilution in mineral oil) for treating nausea associated with acute migraine attacks.

Conditions Studied

Interventions

  • OTHER Eucalyptus Oil Scent
  • OTHER Isopropyl Alcohol Vapors

Study Locations (1)

Arizona

  • HonorHealth Bob Bové Neuroscience Institute - Scottsdale

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2021-11-11
Est. Completion 2026-01-31
Phase NA

Sponsor

HonorHealth Research Institute

20 total trials

What the Registry Record Tells You About NCT05175521

The ClinicalTrials.gov registry entry for NCT05175521 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (86% lower). The listed sponsor is HonorHealth Research Institute, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 2 interventions - of which Eucalyptus Oil Scent is the first listed.

NCT05175521 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT05175521 about?

NCT05175521 is a clinical study titled "Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine". The goal of this study is to compare the efficacy and adverse events of inhaled isopropyl alcohol vapor (IAV) versus placebo (inhaled eucalyptus scent (IES) (1:20 dilution in mineral oil) for treating nausea associated with acute migraine attacks.

What is the current status of trial NCT05175521?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2021-11-11. Estimated completion is 2026-01-31.

What conditions does trial NCT05175521 study?

This clinical trial studies the following conditions: Migraine.

What interventions are being tested in trial NCT05175521?

The interventions under investigation include: Eucalyptus Oil Scent (OTHER), Isopropyl Alcohol Vapors (OTHER).

Who is sponsoring clinical trial NCT05175521?

This trial is sponsored by HonorHealth Research Institute, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05175521 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.